Dr. Jay D. Geller

Alejandro Gru, MD is the Leonard C. Harber Professor of Dermatology and Director of Dermatopathology at Columbia University Irving Medical Center. He is also the Director of the Dermatopathology Fellowship and holds a joint appointment with the Pathology & Cell Biology Department. Dr. Gru received his MD from the Universidad de Buenos Aires in Argentina. He completed his internship in Medicine and residency training in Anatomic Pathology, followed by fellowship training in Surgical Pathology, Hematopathology, and Dermatopathology at Washington University School of Medicine in St. Louis. He subsequently joined the faculty at Ohio State University as an Assistant Professor of Pathology and Dermatology prior to moving to the University of Virginia, where he was promoted to Associate Professor and then tenured Professor in the Department of Pathology. At the University of Virginia, he established the first cutaneous lymphoma multidisciplinary program and served as director of the Dermatopathology section and fellowship.Dr. Gru is the current President of the United States Cutaneous Lymphoma Consortium (USCLC) and has led the pathology initiatives of the international study in advanced stage cutaneous lymphomas (PROCLIPI), the USCLC lymphoma registry, and more recently the International T-cell Lymphoma Project (TCP 2.0). He is an associate editor for the Journal of Cutaneous Pathology and Seminars in Diagnostic Pathology. He serves on the editorial board of numerous academic journals, including the Journal of the American Academy of Dermatology, the American Journal of Surgical Pathology, Modern Pathology, and Histopathology, among others. Dr. Gru is highly rated in 32 conditions, according to our data. His top areas of expertise are T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Erythroderma, Exfoliative Dermatitis, and Tissue Biopsy.

Dr. Sameera Husain is a Professor in the Department of Dermatology of the Vagelos College of Physicians and Surgeons at Columbia University. She joined the full-time faculty of the Department of Dermatology in 1999 and has been an active member of the university community ever since. Prior to this (1997-1999), she served as a Consulting Dermatopathologist, in the Departments of Pathology at St Lukes-Roosevelt Hospital Center, as well as at Beth Israel Medical Center. Dr. Husain received her medical degree from Dow Medical College, Karachi, Pakistan. She completed her Pathology residency and Surgical Pathology fellowship at Columbia University Medical Center, New York, and her fellowship in Dermatopathology at Cornell University Medical Center, New York with Dr. Scott McNutt. Dr. Husain is board certified in both Pathology and Dermatopathology.As one of four Dermatopathologists in the department, Dr. Husain sees a large volume of biopsies (which over the years has ranged up to 43,000 specimens per year), all within a turnaround time of 24-48 hours. Her areas of special interest include alopecias, infectious diseases and lymphoproliferative disorders. She actively publishes in peer-reviewed journals and routinely participates in and presents at international Dermatopathology and Pathology meetings. As appreciation of her high standards of patient care and academic responsibilities, she was recently (2020) inducted into the Academy of Clinical Excellence at Columbia University.Additionally, Dr. Husain actively lectures Dermatopathology residents, and Pathology residents on a range of specialized topics in dermatopathology. Appreciation for her educational commitment has come in the form of three resident-awarded “Teacher of the Year” awards over the past few years.Dr. Husain is a fellow of the American Society of Dermatopathology and member of the New York Dermatologic Society. Dr. Husain is highly rated in 31 conditions, according to our data. Her top areas of expertise are Warts, Actinic Keratosis, Basal Cell Skin Cancer, and Syringocystadenoma Papilliferum.

Adnan Savera is a Pathologist in Montclair, New Jersey. Dr. Savera is highly rated in 20 conditions, according to our data. His top areas of expertise are Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, and Urothelial Cancer.